CEO: Christian Itin

Sector: Healthcare

Exchange: Nasdaq Global Select

Country: USA

Description: Autolus Therapeutics PLC is a biopharmaceutical company. It is engaged in the development of next-generation programmed T cell therapies for the treatment of cancer. The company's pipeline includes AUTO1, AUTO2, AUTO3, AUTO4, and AUTO6.

Key numbers

Market Capitalization:839101788
Shares Outstanding: 52247932
Float: 52171493
Next Earning Date:2020-08-06
TTm EPS: -2.7802
TTm Dividend Rate:
200 days moving average:11.23
50 days moving average: 11.92
One day percent Change: -6.87

2016-09-30, 2017-09-30, 2018-09-30, 2018-12-31,
2016-09-30, 2017-09-30, 2018-09-30, 2018-12-31,